As of 2025-07-04, the Intrinsic Value of Genomed SA (GEN.WA) is 20.62 PLN. This GEN.WA valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 25.40 PLN, the upside of Genomed SA is -18.80%.
The range of the Intrinsic Value is 17.09 - 27.40 PLN
Based on its market price of 25.40 PLN and our intrinsic valuation, Genomed SA (GEN.WA) is overvalued by 18.80%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 17.09 - 27.40 | 20.62 | -18.8% |
| DCF (Growth 10y) | 18.43 - 28.07 | 21.76 | -14.3% |
| DCF (EBITDA 5y) | 23.10 - 26.10 | 24.01 | -5.5% |
| DCF (EBITDA 10y) | 22.94 - 26.35 | 24.13 | -5.0% |
| Fair Value | 20.93 - 20.93 | 20.93 | -17.59% |
| P/E | 20.85 - 35.35 | 28.75 | 13.2% |
| EV/EBITDA | 21.97 - 27.19 | 24.80 | -2.4% |
| EPV | 25.25 - 28.83 | 27.04 | 6.5% |
| DDM - Stable | 6.36 - 14.92 | 10.64 | -58.1% |
| DDM - Multi | 7.46 - 13.79 | 9.70 | -61.8% |
| Market Cap (mil) | 33.53 |
| Beta | -0.24 |
| Outstanding shares (mil) | 1.32 |
| Enterprise Value (mil) | 28.29 |
| Market risk premium | 6.34% |
| Cost of Equity | 9.13% |
| Cost of Debt | 5.00% |
| WACC | 6.86% |